Theravance Biopharma Inc (TBPH)
Cash & Equivalents
$219.77M
Quarterly · Period ending: · USD
TBPH Cash & Equivalents
Latest reported$219.77Mperiod ending
Latest reported$219.77Mperiod ending
TBPH Quarterly Cash & Equivalents ($0.00 → $219.77M)
Quarterly Cash & Equivalents
High-resolution chart · PNG
TBPH cash & equivalents history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 219,766,000 | |
| 288,101,000 | |
| 167,806,000 | |
| 174,773,000 | |
| 281,927,000 | |
| 110,614,000 | |
| 37,797,000 | |
| 23,378,000 | |
| 46,345,000 | |
| 53,835,000 | |
| 39,545,000 | |
| 71,685,000 | |
| 105,596,000 | |
| 187,665,000 | |
| 298,172,000 | |
| 418,538,000 | |
| 87,292,000 | |
| 94,367,000 | |
| 89,959,000 | |
| 121,424,000 | |
| 204,949,000 | |
| 114,011,000 | |
| 81,467,000 | |
| 93,282,000 | |
| 104,735,000 | |
| 332,798,000 | |
| 58,064,000 | |
| 102,403,000 | |
| 178,311,000 | |
| 223,235,000 | |
| 378,021,000 | |
| 101,202,000 | |
| 103,854,000 | |
| 125,831,000 | |
| 88,980,000 | |
| 91,301,000 | |
| 139,626,000 | |
| 169,945,000 | |
| 344,709,000 | |
| 86,572,000 | |
| 148,363,000 | |
| 128,803,000 | |
| 112,707,000 | |
| 127,114,000 | |
| 97,090,000 | |
| 100,899,000 | |
| 89,215,000 | |
| 122,228,000 | |
| 268,199,000 | |
| 833,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |